| Acute Coronary Syndrome |
1 |
1 |
| Thromboembolism |
0 |
0.9 |
| Artery |
0 |
0.67 |
| Cardiovascular Imaging |
0 |
0.52 |
| Anticoagulation Therapy |
0 |
0.98 |
| Direct Factor Xa Inhibitor |
0 |
0.38 |
| Ultrasonography |
0 |
0.29 |
| Renal Failure |
0 |
0.25 |
| Angiography |
0 |
0.19 |
| Hemorrhage |
0 |
0.19 |
| Hospital |
0 |
0.19 |
| Percutaneous Coronary Intervention |
0 |
0.99 |
| Aneurysm |
0 |
0.13 |
| Deep Venous Thrombosis |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.13 |
| Hypertension |
0 |
0.13 |
| Lipids Management |
0 |
0.13 |
| Tobacco Cessation |
0 |
0.13 |
| Body Mass Index |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| New York |
0 |
0.1 |
| Prophylaxis |
0 |
0.1 |
| Smoking |
0 |
0.1 |
| Statins |
0 |
0.1 |
| Thrombus |
0 |
0.1 |
| Unfractionated Heparin |
0 |
0.1 |